The {pharmaceutical market is increasingly exploring novel treatment strategies for metabolic conditions, and the introduction of semaglutide 10mg vials represents a significant advancement . Clinicians are now evaluate the possible benefits and drawbacks associated with this stronger strength product, especially in contrast with existing lower-dos